Drug-induced asterixis in Parkinson disease

Area of Science:

• Neurology
• Pharmacology

Background:

• Parkinson's disease is a progressive neurodegenerative disorder.
• Levodopa is a primary treatment for Parkinson's disease, aiming to replenish dopamine levels.

Observation:

• Asterixis, or "liver flap," was noted in five patients with Parkinson's disease undergoing levodopa therapy.
• A prospective study identified asterixis in 4 out of 55 consecutive Parkinson's patients.

Findings:

• Asterixis occurred within a toxic confusional state, alongside dementia, insomnia, hallucinosis, and myoclonus.
• All patients exhibited normal liver and metabolic function tests, suggesting a non-hepatic cause.
• The asterixis resolved upon discontinuation of levodopa, indicating a drug-related etiology.

Implications:

• Levodopa may induce asterixis in patients with Parkinson's disease, particularly those with dementia.
• This highlights the importance of monitoring for drug toxicity in Parkinson's patients.
• Recognizing drug-induced asterixis is crucial for accurate diagnosis and treatment adjustment.